flap breast reconstruction surgery. Most surgeons recommend first dose of low molecular weight heparin (LMWH) to be administered at 6-12 hours post operatively. We assessed therefore adherence ... cycle; 50 patients in…
Physicians (ACCP) prefer the use of secondary anticoagulant thromboprophylaxis with low molecular weight heparin (LMWH). It is supposed that such antithrombotic prevention provides also antiinflammatory and…
effective anticoagulation strategies, which typically utilize anticoagu-lants such as low-molecularweight heparin (LMWH), fonda-parinux, or warfarin.4- 6In recent years, the role of direct oral anticoagulants(DOACs) in…
implantation). The number of patients bridging from apixaban to heparin/low-molecular-weight heparin (LMWH) was higher for ablation than for the other procedures (51.2% for ablation ... hours. Comparing patients with…
treatment of cancer-related venous thromboembolism has been low molecular weight heparin (LMWH) for several years. But treatment with direct oral anticoagulants (DOACs) may represent an alternative to LMWH ... venous…
following three groups: 63 patients were given subcutaneous injection of low-molecular-weight heparin (LMWH) (group A), 63 patients were given continuous intravenous argatroban (group B) and 63 patients were ... given…
following three groups: 63 patients were given subcutaneous injection of low-molecularweight heparin (LMWH) (group A), 63 patients were given continuous intravenous argatroban (group B) and 63 patients were given…
following three groups: 63 patients were given subcutaneous injection of low-molecularweight heparin (LMWH) (group A), 63 patients were given continuous intravenous argatroban (group B) and 63 patients were given…
issues is urgently needed to be addressed. Methodology & Theoretical Orientation: The anti-angiogenic polysaccharide LMWH was derived to be bioactive drug carriers for tumor nanotherapy. LMWH-Gemcitabine-Cholesterol…
have accepted applications for compounds, like peg-filgrastim, insulin, LMWH when validated surrogate markers of efficacy are available, as long as a state-of-the-art chemistry, manufacturing, and controls
patients were treated with anticoagulant therapy: 19 (54,3%) with Low molecular Weight Heparin (LMWH), 3 (8,6%) with Fondaparinux, 5 (14,3%) with LMWH and Direct Oral Anticoagulants (DOACs
These parameters started to normalize at BS5. Based on the results, the change in LMWH dose was recommended most frequently in BS4 and in one patient in BS3. Conclusion & Significance ... haemostasis may be useful…
vein (71,4%). As regards the treatment 52,4% of patients was treated with LMWH, 14,3% with fondaparinux, 52,4% with DOAC. There were no cases of pulmonary embolism ... adverse events related to the therapy, we observed…
this manner recommended either thrombo-embolic-obstacle stockings (TEDS)/low atomic weight heparin (LMWH) for the anticipation of VTE dependent on their score. A review casenote review of an arbitrary ... finished. In…
gradually obstructed her airway. The bleeding was complicated by her history of hypertension and LMWH. The patient made a full recovery and left the hospital after 10 days. Literature
first year from diagnosis). The needing for anticoagulation with low molecular weight heparin (LMWH) in patients who are at high risk for complications (risk of bleeding in digestive tumors, brain ... complications such…
primarily focussed on thrombin inhibitors, mainly, cumarins (warfarin), low molecular weight heparins (LMWH) and, more recently, new, direct acting oral anticoagulants (NOAC). However, there may also be a role ... that…
spinal distraction without fusion was carried out. Prophylactic treatment with low molecular weight heparin (LMWH) was started on day 2 after surgery. Results: LMWH treatment was stopped
which 2.5% of patients developed venous thrombosis. Three patients were treated successfully with LMWH during their consolidation phase of chemotherapy. Conclusion: Venous thrombosis in acute leukemia is not uncommon…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.